Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 5/15/2026CDE Issues New TCM Post-Approval Change Review Guidelines
  • 5/15/2026CDE Issues Revised Review Guideline for Biologics Change Applications
  • 5/15/2026CDE Releases Revised Review Guideline for Chemical Drug Change Applica...
  • 5/15/2026CDE Releases Operational Procedures for Drug Trial Data Protection Sys...
  • 5/15/2026CDE Issues Filing Requirements for Drug Data Protection Applications
  • 5/15/2026China Introduces Drug Trial Data Protection Rules to Strengthen Pharma...
  • 5/14/2026Singapore and China Sign MoU to Strengthen Cooperation on Health Produ...
  • 5/14/2026China Launches Sweeping Crackdown on Pharmaceutical Kickbacks and Sale...
  • 5/13/20262025 Annual Drug Evaluation Report: Chinese Applications and Reviews H...
  • 5/12/2026Singapore, China Expand Regulatory Partnership to Include Gene and Cel...
  • 5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
  • 5/11/2026NMPA Releases 105th Batch of Generic Drug Reference Formulations
  • 5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
  • 5/8/2026CDE Issues Revised Technical Guideline for Recombinant Insulin Product...
  • 5/8/2026China Reports 3.05M ADRs in 2025, Flags Oncology and Anti-Infective Ri...
  • 5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...
  • 5/6/2026NHC Seeks Public Feedback on Updated Rules for Managing Narcotic and P...
  • 5/6/2026China Formalizes Approval Framework for Clinical Use of Biomedical New...
  • 5/6/2026NHC Releases Trial Rules for Approving Clinical Use of Biomedical New ...
  • 5/6/2026NHC Issues Interim Rules Defining Boundaries Between Biomedical New Te...
  • 4/29/2026CDE Seeks Feedback on Draft Bioanalytical Lab Compliance Report for Cl...
  • 4/29/2026CDE Opens Consultation on BNCT Drug Development Guideline
  • 4/28/2026China Moves to Expand Maternity Insurance Coverage in Draft Healthcare...
  • 4/27/2026China NMPA Releases Updated Procedures for Conditional Drug Approvals
  • 4/24/2026China Seeks Feedback on New Approval Framework for Clinical Translati...
  • 4/24/2026CDE Issues New Framework for Post-Approval Changes and Registration Te...
  • 4/23/2026CDE Issues New Guidance Table on Post-Approval Changes and Triggering ...
  • 4/22/2026CDE Opens Public Consultation on 106th Batch of Reference Formulations...
  • 4/22/2026China Suspends Import and Use of Colchicine API from Two Indian Manufa...
  • 4/22/2026China Unveils Landmark Drug Pricing Framework to Boost Innovation and ...
  • Page:1/9 Total number of articles:257: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group